Relationship Between Body Weight and Glycohemoglobin

Relationship Between Changes in Body Weight and Glycohemoglobin Levels in Patients With Type 2 Diabetes Treated With Diet or Pioglitazone.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00892372

Enrollment

100

Registered

2009-05-04

Start date

2009-04-30

Completion date

2009-04-30

Last updated

2009-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes Mellitus

Keywords

body weight, glycohemoglobin

Brief summary

Control of body weight (BW) is important to prevent and manage type 2 diabetes. Regardless of the close association, little is understood about the precise relationship between BW and glycemic control, which might be of benefit for patients with type 2 diabetes. The researchers investigated the correlation between changes in BW and glycemic control in patients with type 2 diabetes treated with a diet therapy or pioglitazone.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

32 Years to 76 Years

Healthy volunteers

Inclusion criteria

* type 2 diabetes under reasonable glycemic control (HbA1c; less than around 7%) * type 2 diabetic patients treated with the diet therapy

Exclusion criteria

* type 2 diabetic patients with edema, severe liver dysfunction, renal dysfunction, moderate to severe anemia or congestive heart failure * type 2 diabetic patients treated with insulin therapy

Countries

Japan

Outcome results